Profile
Sector:
Consumer DefensiveIndustry:
Packaged FoodsCountry:
United StatesIPO:
15 May 2015Website:
http://www.arcadiabio.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 21:29:26 GMTDividend
Analysts recommendations
Institutional Ownership
RKDA Latest News
Arcadia Biosciences (RKDA) is using the sale of its GoodWheat brand to expand its wheat intellectual property.
Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will be hosting a call for analysts and investors on May 22, 2024, after the market closes. The conference call, scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time), will focus on recent strategic transactions. Interested participants can join the call through an audio-only webcast.
Arcadia Biosciences (RKDA) saw improved Q1 results due to a reduction in operating costs.
Arcadia Biosciences, Inc. and Above Food Corp. have announced that Above Food will acquire the GoodWheatTM brand from Arcadia for $4 million. This marks the start of a partnership between the two companies.
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a company specializing in plant-based health and wellness products, will report its financial and business results for the first quarter of 2024 after the market closes on May 9, 2024. A conference call is scheduled for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss the results and strategic accomplishments. Those interested can participate in the conference call.
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript
Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago.
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President and Chief Executive Officer Conference Call Participants Dipesh Patel - H.C.
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2023 after market close on November 9, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference.
What type of business is Arcadia Biosciences?
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
What sector is Arcadia Biosciences in?
Arcadia Biosciences is in the Consumer Defensive sector
What industry is Arcadia Biosciences in?
Arcadia Biosciences is in the Packaged Foods industry
What country is Arcadia Biosciences from?
Arcadia Biosciences is headquartered in United States
When did Arcadia Biosciences go public?
Arcadia Biosciences initial public offering (IPO) was on 15 May 2015
What is Arcadia Biosciences website?
https://www.arcadiabio.com
Is Arcadia Biosciences in the S&P 500?
No, Arcadia Biosciences is not included in the S&P 500 index
Is Arcadia Biosciences in the NASDAQ 100?
No, Arcadia Biosciences is not included in the NASDAQ 100 index
Is Arcadia Biosciences in the Dow Jones?
No, Arcadia Biosciences is not included in the Dow Jones index
When does Arcadia Biosciences report earnings?
The next expected earnings date for Arcadia Biosciences is 09 August 2024